Baillie Gifford acquired 8.04M BioNTech SE shares worth $832M. That's 0.60% of their equity portfolio (31st largest holding). The investor owns 3.46% of the outstanding BioNTech SE stock. The first BioNTech SE trade was made in Q1 2021. Since then Baillie Gifford bought shares seven more times and sold shares on ten occasions. The investor's estimated purchase price is $935M, resulting in a loss of 11%.